Literature DB >> 9514213

Alkaline phosphatase levels and osteoprogenitor cell numbers suggest bone formation may contribute to peak bone density differences between two inbred strains of mice.

H P Dimai1, T A Linkhart, S G Linkhart, L R Donahue, W G Beamer, C J Rosen, J R Farley, D J Baylink.   

Abstract

Previous studies have shown that C3H/HeJ (C3H) mice have higher peak bone density than C57BL/6J (B6) mice, at least in part because of differences in rates of bone resorption. The current studies were intended to examine the alternative, additional hypothesis that the greater bone density in C3H mice might also be a consequence of increased bone formation. To that end, we measured two presumptive, indirect indices of bone formation and osteoblast number in these inbred strains of mice: alkaline phosphatase (ALP) activity in serum, bones, and bone cells; and the number of ALP-positive colony-forming units (CFU) in bone marrow stromal cell cultures. We found that C3H mice had higher serum levels of ALP activity than B6 mice at 6 (118 vs. 100 U/L, p < 0.03) and 32 weeks of age (22.2 vs. 17.2 U/L, p < 0.001). Tibiae from C3H mice also contained higher levels of ALP activity than tibiae from B6 mice at 6 (417 vs. 254 mU/mg protein, p < 0.02) and 14 weeks of age (132 vs. 79 mU/mg protein, p < 0.001), as did monolayer cultures of bone-derived cells from explants of 7.5-week-old C3H calvariae and femora (8.2 times more, p < 0.02, and 4.6 times more, p < 0.001, respectively). Monolayer cell cultures prepared by collagenase digestion of calvariae from newborn and 6-week-old mice also showed similar strain-dependent differences in ALP-specific activity (p < 0.001 for each). Our studies also showed more ALP-positive CFU in bone marrow stromal cell cultures from 8-week-old C3H mice, compared with B6 mice (72.3 vs. 26.1 ALP-positive CFU/culture dish, p < 0.001). A similar result was seen for ALP-positive CFU production at 6 and 14 weeks of age, and the difference was greatest for the CFU that contained the greatest numbers of ALP-positive cells. Because skeletal ALP activity is a product of osteoblasts and has been shown to correlate with rates of bone formation, and because the number of ALP-positive CFU is believed to reflect the number of osteoprogenitor cells, the current data are consistent with the general hypothesis that bone formation may be greater in C3H than B6 mice because of a difference in osteoblast number. Our data further suggest that peak bone density may be greater in C3H mice than B6 mice due to a combination of decreased bone resorption and increased bone formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514213     DOI: 10.1016/s8756-3282(97)00268-8

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  16 in total

Review 1.  A strategy for identifying osteoporosis risk genes.

Authors:  David Rowe; Alexander Lichtler
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

2.  Bone matrix mineralization is preserved during early perimenopausal stage in healthy women: a paired biopsy study.

Authors:  B M Misof; P Roschger; S Blouin; R Recker; K Klaushofer
Journal:  Osteoporos Int       Date:  2015-12-09       Impact factor: 4.507

3.  Osteopoietic engraftment after bone marrow transplantation: effect of inbred strain of mice.

Authors:  Satoru Otsuru; Ted J Hofmann; Valeria Rasini; Elena Veronesi; Massimo Dominici; Edwin M Horwitz
Journal:  Exp Hematol       Date:  2010-05-04       Impact factor: 3.084

4.  Systemic injection of CK2.3, a novel peptide acting downstream of bone morphogenetic protein receptor BMPRIa, leads to increased trabecular bone mass.

Authors:  Hemanth Akkiraju; Jeremy Bonor; Kristine Olli; Chris Bowen; Beth Bragdon; Harold Coombs; Leah Rae Donahue; Randall Duncan; Anja Nohe
Journal:  J Orthop Res       Date:  2014-10-20       Impact factor: 3.494

5.  Evidence that IGF-binding protein-5 functions as a growth factor.

Authors:  N Miyakoshi; C Richman; Y Kasukawa; T A Linkhart; D J Baylink; S Mohan
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

6.  Antiosteoporotic activity of a syringic acid diet in ovariectomized mice.

Authors:  Teruyoshi Tanaka; Nobuhisa Kawaguchi; Nobuhiro Zaima; Tatsuya Moriyama; Yasuhisa Fukuta; Norifumi Shirasaka
Journal:  J Nat Med       Date:  2017-07-05       Impact factor: 2.343

7.  Mechanical stimulation of bone formation is normal in the SAMP6 mouse.

Authors:  Matthew J Silva; Michael D Brodt
Journal:  Calcif Tissue Int       Date:  2008-06       Impact factor: 4.333

8.  Modulation of murine bone marrow-derived CFU-F and CFU-OB by in vivo bisphosphonate and fluoride treatments.

Authors:  M-Y Chou; D Yan; T Jafarov; E T Everett
Journal:  Orthod Craniofac Res       Date:  2009-05       Impact factor: 1.826

9.  Genetic background influences fluoride's effects on osteoclastogenesis.

Authors:  Dong Yan; Aruna Gurumurthy; Maggie Wright; T Wayne Pfeiler; Elizabeth G Loboa; Eric T Everett
Journal:  Bone       Date:  2007-08-08       Impact factor: 4.398

10.  5-Azacytidine facilitates osteogenic gene expression and differentiation of mesenchymal stem cells by alteration in DNA methylation.

Authors:  Guo-Shun Zhou; Xiao-Lei Zhang; Jun-Ping Wu; Rui-Peng Zhang; Li-Xin Xiang; Li-Cheng Dai; Jian-Zhong Shao
Journal:  Cytotechnology       Date:  2009-06-26       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.